[ORGANIZATION]
Ocugen, Inc.
Featured in 1 tracked story · first seen
Situations
Ocugen clinical trial results and market performance
2 clusters · 6 sources · last updated
Latest: Ocugen earnings estimates raised as Oculis board member resigns
Ocugen experienced significant market volatility following an interim analysis of its OCU410ST gene therapy study for Stargardt disease. Data from the first 26 participants indicated a “negative treatment effect,” causin